Victory Capital Management
TVTX icon

Victory Capital Management’s Travere Therapeutics TVTX Stock Holding History

Victory Capital Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32M Buy
111,633
+71,884
+181% +$2.15M ﹤0.01% 1462
2025
Q4 		$1.52M Sell
39,749
-5,786
-13% -$188K ﹤0.01% 1651
2025
Q3 		$1.09M Buy
45,535
+20,886
+85% +$393K ﹤0.01% 1798
2025
Q2 		$365K Buy
24,649
+14,108
+134% +$234K ﹤0.01% 2112
2025
Q1 		$189K Buy
10,541
+78
+0.7% +$1.58K ﹤0.01% 2234
2024
Q4 		$182K Buy
+10,463
New +$185K ﹤0.01% 2256
2022
Q4 		– Sell
-17,547
Closed -$432K – 2707
2022
Q3 		$432K Sell
17,547
-1,092
-6% -$28.2K ﹤0.01% 2111
2022
Q2 		$452K Buy
18,639
+480
+3% +$12.1K ﹤0.01% 2100
2022
Q1 		$456K Buy
18,159
+10,410
+134% +$276K ﹤0.01% 2158
2021
Q4 		$241K Buy
+7,749
New +$218K ﹤0.01% 2437
2021
Q2 		– Sell
-8,608
Closed -$215K – 2812
2021
Q1 		$215K Buy
+8,608
New +$238K ﹤0.01% 2510
2020
Q2 		– Sell
-10,008
Closed -$146K – 3235
2020
Q1 		$146K Buy
+10,008
New +$151K ﹤0.01% 2420
2019
Q4 		– Sell
-5,149
Closed -$60K – 3241
2019
Q3 		$60K Buy
+5,149
New +$85.1K ﹤0.01% 2607

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management's TVTX Position: Q1 2026 in Review

Victory Capital Management increased its Travere Therapeutics (TVTX) stake by 181% in Q1 2026, buying an estimated $2.15M and bringing the position to 111,633 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Victory Capital Management first reported a position in TVTX in Q3 2019 and has held it in 13 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Victory Capital Management held 111,633 shares of Travere Therapeutics worth $3.32M as of Q1 2026.
  • Victory Capital Management bought 71,884 Travere Therapeutics shares in Q1 2026, an estimated $2.15M.
  • Travere Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1462 holding.
  • Victory Capital Management first reported a position in Travere Therapeutics in Q3 2019 and has held it in 13 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.